The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in BioNTech (BNTX). While the effectiveness of this highly sought-after metric is questionable, the ...
Problems anticipated as jabs developed more quickly and with less extensive clinical trials than the norm ...
The Trump administration had an opportunity to spark a resurgence in American innovation through intellectual property reform ...
Today in History for Jan. 29: ...
Ipsen Biopharmaceuticals must face a former patient safety employee’s religious bias claims over her alleged firing for ...
Adriel Chen and Devi Sridhar discuss the outbreak of Paediatric Inflammatory Multisystem Syndrome in 2020 and consider what lessons we can learn In mid-March 2020 and into April 2020, paediatric wards ...
The net interest margin narrowed from 3.62% in the third quarter of 2024 to 3.58% in the fourth quarter of 2024. The ...